TipRanks
X4 Pharmaceuticals Inc (DE:48Q0)
FRANKFURT:48Q0
Germany Market
48Q0
X4 Pharmaceuticals
RESEARCH TOOLSreports

X4 Pharmaceuticals (48Q0) Income Statement

3 Followers

X4 Pharmaceuticals Income Statement

Last quarter (Q2 2026), X4 Pharmaceuticals's total revenue was $8.81M, an increase of 346.33% from the same quarter last year. In Q2, X4 Pharmaceuticals's net income was $-16.16M. See X4 Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 35.11M$ 2.56M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 28.86M$ 1.76M$ 0.00$ 0.00$ -1.89M
Operating Expenses
$ 115.74M$ 38.16M$ 107.52M$ 87.57M$ 73.46M
Depreciation and Amortization
$ 1.28M$ 796.00K$ 419.00K$ 513.00K$ 1.89M
EBITDA
$ -69.00M$ -27.58M$ -94.89M$ -89.33M$ -83.14M
Operating Income
$ -86.88M$ -36.40M$ -107.52M$ -87.57M$ -75.35M
Other Income/Expenses
$ 7.72M$ -739.00K$ 6.43M$ -6.27M$ -13.33M
Pretax Income
$ -79.16M$ -37.14M$ -101.09M$ -93.84M$ -88.68M
Net Income
$ -79.20M$ -37.45M$ -101.17M$ -93.87M$ -88.70M
Per Share Metrics
Basic EPS
$ -1.87$ -5.59$ -17.07$ -45.60$ -119.58
Diluted EPS
$ -1.87$ -5.59$ -17.07$ -45.60$ -119.58
Weighted Average Shares Outstanding
 42.29M 6.70M 5.93M 2.12M 858.30K
Weighted Average Shares Outstanding (Diluted)
 42.29M 6.70M 5.93M 2.12M 858.30K
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History